Back to Results
First PageMeta Content
Latent tuberculosis / Pyrazinamide / Cochlear implant / Abacavir / Olanzapine / Rifampicin / Food and Drug Administration / Patient safety / Tuberculosis treatment / Medicine / Tuberculosis / Health


FDA Patient Safety News: Show #20, October 2003
Add to Reading List

Open Document

File Size: 91,31 KB

Share Result on Facebook
UPDATE